Bintang Samudera Mandiri Lines Tbk vs Ikapharmindo Putramas Tbk. — how do they compare? Bintang Samudera Mandiri Lines Tbk trades at Rp520 (market cap 952.87B, 18.7M 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume). The key difference: Bintang Samudera Mandiri Lines Tbk is far larger — about 3.1× Ikapharmindo Putramas Tbk.'s market cap, and Bintang Samudera Mandiri Lines Tbk is more actively traded (18.7M versus 13.7K). Which is the better fit depends on your goals.
| BSML | IKPM | |
|---|---|---|
Market Cap | 952.87B | 304.92B |
Volume | 18.7M | 13.7K |
Lot | 187.04K | 137 |
Turnover | 9.68B | 2.49M |
Average Price | 517.75 | 181.39 |
Value | 9.68B | 2.49M |
Indicative Equilibrium Price | 520 | — |
Indicative Equilibrium Volume | 31 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Bintang Samudera Mandiri Lines Tbk (the Company) was established based on Notarial Deed No. 101 of Fransiskus Djoenardi, S.H., dated November 17, 2007. The Company has started its operations since 2017.
Read more on BSML →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →